The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application notesICC/IF: Use at a concentration of 2 - 4 ug/ml.
IP: Use at 2-4 ug.
WB: Use at a concentration of 1 - 2 ug/ml. Detects a band of approximately 45 kDa (predicted molecular weight: 45 kDa).
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
FunctionNAD-dependent protein deacetylase that specifically mediates deacetylation of histone H3 at 'Lys-18' (H3K18Ac). In contrast to other histone deacetylases, displays selectivity for a single histone mark, H3K18Ac, directly linked to control of gene expression. H3K18Ac is mainly present around the transcription start site of genes and has been linked to activation of nuclear hormone receptors. SIRT7 thereby acts as a transcription repressor. Moreover, H3K18 hypoacetylation has been reported as a marker of malignancy in various cancers and seems to maintain the transformed phenotype of cancer cells. These data suggest that SIRT7 may play a key role in oncogenic transformation by suppresses expression of tumor suppressor genes by locus-specific deacetylation of H3K18Ac at promoter regions. Also required to restore the transcription of ribosomal RNA (rRNA) at the exit from mitosis: promotes the association of RNA polymerase I with the rDNA promoter region and coding region. Stimulates transcription activity of the RNA polymerase I complex. May also deacetylate p53/TP53 and promotes cell survival, however such data need additional confirmation.
Sequence similaritiesBelongs to the sirtuin family. Class IV subfamily. Contains 1 deacetylase sirtuin-type domain.
Post-translational modificationsPhosphorylated during mitosis.
Cellular localizationCytoplasm. Nucleus, nucleolus. Located close to the nuclear membrane when in the cytoplasm. Associated with chromatin. Associated with rDNA promoter and transcribed region. Associated with nucleolar organizer regions during mitosis.
Human HEK-293T cells were fixed and permeabilized with 4% paraformaldehyde followed by 0.2% Triton-X-100. Cells were stained with 2.5 µg/mL Anti-SIRT7 (ab62748) and developed with Goat Anti-Rabbit IgG, Cy3 conjugate (A), or stained with DAPI (B).
Immunoprecipitation - SIRT7 antibody (ab62748)
ab62748 was used to immunoprecipitate SIRT7 from HEK-293T cells expressing recombinant human SIRT7-V5. Detection antibody: Monoclonal Anti-V5 antibody.
1: 2 µg Antibody
2: 4 µg Antibody
3: Negative control (without primary antibody)
References for Anti-SIRT7 antibody (ab62748)
has not yet been referenced specifically in any publications.
Publishing research using ab62748? Please let us know so that we can cite the reference in this datasheet.
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"